GSK and Lifetime ® launch original movie to raise awareness about the impact of meningitis
The film follows Julie, played by actress Haylie Duff, a relatable mom juggling the demands of family life and a career, while navigating the challenges of parenting a teen in high school. After Julie's daughter, Lauren, enters a beauty pageant to win scholarship money for college, meningitis suddenly strikes close to home, showcasing the impact of the disease on both their family and an entire community.
As the newest spokesperson for the larger Ask2BSure campaign, Alyson Hannigan, seasoned actress and mom to a 16-year-old, knows parenting teens is a job with no script. Hannigan was moved to join Ask2BSure after hearing the real stories of families impacted by meningitis. GSK honors the experiences of those families with this Lifetime movie.
Hannigan said: 'As a mom, I know how hard it can be to stay on top of everything, especially when it comes to my teen's health, and it is so important to ask the right questions about meningitis risk and vaccination. I'm proud to have joined the Ask2BSure campaign so that I can empower other parents to speak up and ask their teen's doctor for more information.' 4
Pretty Hurts builds off the 2023 GSK and Lifetime co-branded short film, 'I Never Thought to Ask: A Mom's Quest for Answers,' which also brought awareness to meningitis B and vaccination.
Cynthia Burman, US Medical Affairs Lead for Neisseria Vaccines for GSK, said: 'Working with Lifetime on this longer-form creative and educational film allows us to deliver impactful content to help empower parents in the US to start the conversation with their teen's doctor to find out if their teen is missing any meningococcal vaccinations.' 4,5
Pretty Hurts is intended for viewers in the US. The movie premieres on Lifetime on June 28 at 8 p.m. ET and will be available for viewing starting June 29 on MyLifetime.com/movies.
About GSK's Ask2BSure Campaign
Ask2BSure aims to educate and empower parents of teens and young adults to start meningitis conversations with their teen's doctors and 'ask to be sure' their teen has received vaccination to help protect against all five vaccine-preventable serogroups of meningitis. Vaccination may not protect all recipients. Find out more at Ask2BSure.com.
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at gsk.com.
Cautionary statement regarding forward-looking statements
GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described under Item 3.D 'Risk factors' in GSK's Annual Report on Form 20-F for 2024.
References:
1. Centers for Disease Control and Prevention. Risk Factors for Meningococcal Disease. Meningococcal Disease. Available at: https://www.cdc.gov/meningococcal/risk-factors/index.html#cdc_risk_factors_who-people-at-increased-risk. Accessed May 2025.
2. Centers for Disease Control and Prevention. Meningococcal Disease Surveillance and Trends. Meningococcal Disease. Available at: https://www.cdc.gov/meningococcal/php/surveillance/index.html. Accessed May 2025.
3. Centers for Disease Control and Prevention. Clinical Overview of Meningococcal Disease. Available at https://www.cdc.gov/meningococcal/hcp/clinical/index.html. Accessed May 2025.
4. Pingali C, Yankey D, Chen M, et al. National Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey-Teen, United States, 2023. MMWR Morb Mortal Wkly Rep 2024; 73:708–714. Available at: https://www.cdc.gov/mmwr/volumes/73/wr/mm7333a1.htm. Accessed May 2025.
5. Centers for Disease Control and Prevention. Meningococcal Vaccination for Adolescents: Information for Healthcare Professionals. Available at: https://www.cdc.gov/meningococcal/hcp/vaccine-recommendations/?CDC_AAref_Val=https://www.cdc.gov/vaccines/vpd/mening/hcp/adolescent-vaccine.html. Accessed May 2025.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
2 hours ago
- Business Wire
Echo and The Vitamin Outlet Partner: Bringing Hydrogen Water Health to Australians
SALT LAKE CITY & PERTH, Australia--(BUSINESS WIRE)-- Echo, a global leader in hydrogen health, has partnered with The Vitamin Outlet to launch the Echo Flask — now available to Australians seeking science-backed hydration. Echo has teamed up with The Vitamin Outlet to introduce the Echo Flask to Australia. This innovative, app-connected bottle infuses water with molecular hydrogen, offering a powerful antioxidant that supports energy, recovery, and overall cellular health. The Echo Flask is an app-connected bottle that infuses water with molecular hydrogen — a powerful antioxidant that supports energy, recovery, and cellular health. Its advanced PEM technology delivers up to 8 ppm in 20 minutes. 'We're proud to offer the Echo Flask to our customers,' said Kwong Keet Chan, CEO of The Vitamin Outlet. 'It represents a new class of hydration — safe, convenient, and scientifically validated. It fits into our mission to provide premium wellness solutions that Australians can trust.' Backed by peer-reviewed research, hydrogen water is gaining recognition for its potential to reduce oxidative stress and inflammation at the cellular level. The Echo Flask makes this wellness tool more accessible than ever. 'Australians are among the most engaged when it comes to preventative health,' said Josh Carr, CEO of Echo. 'Partnering with The Vitamin Outlet allows us to deliver an elite hydrogen wellness product to a market that values innovation and results.' Available for AUD $470, the Echo Flask is now offered through The Vitamin Outlet's website and at their Bull Creek location in Perth. Key Features of the Echo Flask Generates 5 ppm in 10 minutes, 8 ppm in 20 minutes Echo App for cycle control and hydration tracking Lightweight 350 ml design Smart touchscreen, USB-C charging Chemical-free PEM tech — no byproducts or contaminants A 5-year warranty About Echo Echo is a pioneer in hydrogen health, dedicated to helping people unlock and sustain peak performance by transforming water into a clean source of cellular support. From advanced home water systems to portable wellness solutions, Echo partners with the body to promote internal balance, resilience, and consistent energy. Backed by peer-reviewed science, trusted by health experts, and engineered for everyday living, Echo makes hydrogen health accessible, effective, and transformative. For more information, visit About The Vitamin Outlet With both an online platform and physical presence in Perth, The Vitamin Outlet is a go-to destination for trusted wellness products in Australia. It curates scientifically backed tools that help Australians live better, naturally — combining integrity, education, and service to meet the needs of today's informed consumer.
Business Wire
2 hours ago
- Business Wire
Massive Bio and Prognos Health Announce Strategic Partnership to Expand Oncology Access
BOCA RATON, Fla. & NEW YORK--(BUSINESS WIRE)-- Massive Bio, a leader in AI-enabled oncology trial matching and patient access, and Prognos Health, a provider of actionable lab data, today announced an exclusive, strategic partnership. The collaboration is designed to provide pharmaceutical clients with enhanced, actionable real-world data and insights by combining Massive Bio's deep clinical expertise and network with Prognos Health's robust data harmonization and enrichment framework. This partnership focuses on advancing the patient journey and supporting Massive Bio's mission for oncology patient access and Prognos' mission to unlock the power of data to improve health, particularly in complex clinical populations, including oncology. The integrated platform provides a suite of solutions for pharmaceutical, biotech, and CRO clients. The platform will be available starting in Q4 2025. Massive Bio's prescreening network supports approximately 50,000 cancer patients annually, with a roadmap to scale to 250,000 patients by 2027. Prognos Health offers fully integrated and harmonized lab and health records on more than 325 million de-identified patients. 'Our expertise lies in harmonizing vast, disparate lab data. Through this partnership, we are not just providing data; we are tokenizing it into event-driven intelligence,' said Bill Paquin, Chief Commercial Officer at Prognos Health. 'This is the nervous system for clinical trial enrollment. The combination of tokenization and trigger alerts allows our SYNERGY-AI platform to operate with unprecedented precision and speed,' said Selin Kurnaz, Ph.D., Co-founder and CEO of Massive Bio. 'Partnering with Prognos elevates this by layering rich clinical and genomic data for smarter, faster, real-time, actionable intervention, ensuring no patient or trial opportunity is missed.' 'For an oncologist, the flood of clinical data can be overwhelming. This system cuts through the noise,' said Arturo Loaiza-Bonilla, M.D., Co-founder and Chief Medical Officer of Massive Bio. 'Our prescreening hubs and AI-powered analytics create a mission-control capability that works 24/7 to identify and match patients. This is actionable intelligence at the point of care that directly empowers physicians and accelerates patient access to novel therapies. Together, we're redefining how cancer trials are activated, digitally and AI-enabled, making the process scalable, data-driven, and fundamentally patient-centric.' About Massive Bio: Massive Bio, co-founded by Selin Kurnaz, Arturo Loaiza-Bonilla, and Çağatay Çulcuoğlu, transforms the pharmaceutical value chain with AI-driven solutions. As an AI-enabled real-world data company, it streamlines the patient journey, enhances access to advanced treatment options, and optimizes clinical trials. Massive Bio collaborates with pharmaceutical companies, research organizations, and healthcare institutions worldwide. A founding member of the CancerX public-private partnership and participant in the Cancer Moonshot White House initiative, the company has received recognition from the National Cancer Institute and operates across 17 countries with a global team of over 100 employees. For more information, visit About Prognos Health: Prognos Health is a trusted provider of actionable real-world data (RWD) in the life sciences industry that is driven by its mission to unlock the power of data to improve health. Prognos Health's exclusive, unique datasets unlock valuable insights in complex clinical populations across the entire commercial lifecycle, going beyond traditional RWD offerings. Prognos helps life sciences companies accelerate the development and delivery of innovative therapies and improve health outcomes by offering fully integrated and harmonized lab and health records on more than 325 million de-identified patients. For more information, visit
Business Wire
2 hours ago
- Business Wire
Modern Health Welcomes New Chief Technology Officer and General Counsel
SAN FRANCISCO--(BUSINESS WIRE)-- Modern Health, a leading global workplace mental health platform, today announced the appointments of Chen Cheng as Chief Technology Officer and Erin Brown as General Counsel, along with other company momentum, as it accelerates its mission to make mental health care more accessible, personalized, and effective worldwide. 'Welcoming exceptional leaders like Chen and Erin marks an exciting step forward for Modern Health,' said Matt Levin, CEO of Modern Health. In her role as Chief Technology Officer, Chen Cheng will oversee the company's technology and further scale the platform to provide high-quality, clinically rigorous care across the globe. She brings more than a decade of experience in the health technology sector to Modern Health, including roles at Oscar Health and ZocDoc. As technology plays an increasingly critical role in expanding access to mental health care and support, evidenced by the growing engagement with virtual therapy, coaching, and digital tools, Chen will leverage her tech experience and leadership to help Modern Health advance its innovations. Erin Brown joins Modern Health as General Counsel, bringing more than 20 years of legal experience across the health and benefits space. Brown has amassed a proven track record of guiding high-growth organizations through complex legal and regulatory environments. Prior to Modern Health, Brown was Senior Vice President and Associate General Counsel at Alight Solutions and, before that, Associate General Counsel at Aon Hewitt. Her expertise and strategic counsel will be key as Modern Health continues to expand its global footprint and innovate responsibly in a rapidly evolving industry. 'Welcoming exceptional leaders like Chen and Erin marks an exciting step forward for Modern Health,' said Matt Levin, CEO of Modern Health. 'They each bring a powerful combination of industry expertise and a passion for making mental health care more accessible, personalized, and effective. Their leadership will accelerate our momentum as we scale our impact, drive innovation, and continue delivering meaningful outcomes for the workplaces we support worldwide.' In addition to these appointments, other recent company momentum includes: Modern Health has been named to the 2025 Inc. 5000 list of the fastest-growing private companies in America. The list highlights companies that have demonstrated significant revenue growth over a three-year period and serves as a benchmark for entrepreneurial success and a platform for recognizing the contributions of these businesses to the US economy. Modern Health launches ROI Study that proves mental health care pays off: According to a third-party analysis of 13,000+ members, the most significant savings (60% of total savings) in health care spend for employers come from reaching more employees earlier with support that fits their needs before symptoms escalate. Modern Health's evidence-based Adaptive Care Model delivers an estimated $2.39 return for every dollar invested, based solely on health care cost savings. These compelling findings underscore how Modern Health's Adaptive Care Model improves outcomes and drives down costs by supporting the whole workforce—not just those with severe mental health concerns. Peer-reviewed data shows Modern Health's global mental health model works anywhere: In one of the largest and most diverse real-world studies of its kind, Modern Health examined engagement and clinical outcomes among more than 33,000 members across seven global regions to understand not only how mental health needs vary across regions but also whether a single care model could truly work at a global scale. The study proves that achieving global scale requires more than a one-size-fits-all approach; it demands an adaptive, evidence-based model designed to deliver meaningful results across diverse regions and populations. Modern Health's latest study paints a stark picture of how Gen Z and Millennial employees are faring: In a study of 1,000 American professionals aged 18 to 44, the findings reveal a generation silently struggling under the weight of burnout, financial anxiety, and workplace systems that haven't kept pace with their needs. Among the most striking statistics: 75% blame financial stress for fueling burnout and hurting productivity, 79% sacrifice mental health to meet work demands, and 96% want access to preventative mental health support. The workplace report highlights a troubling reality: too many young workers are quietly pushing through mounting mental health challenges just to keep up at work, underscoring the urgent need to meet people earlier, with care that's proactive, adaptive, and designed to support the mental health of entire workforce populations. Launch of FlexEAP Challenges Outdated Employee Assistance Programs: Modern Health recently launched FlexEAP ('Flex'), a next-gen Employee Assistance Program (EAP) addressing the critical shortcomings of traditional EAPs by delivering rapid access to care, adaptive support extending far beyond crisis intervention, and a seamless, consistent global experience. The product combines Modern Health's Adaptive Care Model with an elite, global provider network to deliver a seamless, personalized mental health experience. Employees can access care, on average, within 24 hours, with fast, frictionless support across therapy, coaching, crisis intervention, and digital self-guided tools. Flex delivers superior outcomes and an upgraded, consumer-grade experience compared to traditional EAPs, while offering flexible pricing, customizable solutions, and risk-sharing based on utilization—empowering employers to better manage costs. Expanded Languages for Pathways: Modern Health is proud to offer its Pathways Collections, offering tailored one-on-one support around a variety of topics, including Workplace Well-being, Family Care, and Physical Well-Being, as a truly multilingual product. Now, members can connect with a Pathway Provider in six additional languages — Spanish, Dutch, Hindi, Portuguese, Japanese, and French. About Modern Health Modern Health is a global leader in adaptive mental health care, dynamically offering multi-modal mental health support that delivers meaningful outcomes at a sustainable, predictable cost. With therapy, psychiatry, coaching, community groups, self-guided tools, and crisis support, we dynamically create individualized care journeys to address a spectrum of mental health needs and preferences with culturally responsive providers in 200+ countries and territories and 80+ languages. Backed by peer-reviewed research and a proprietary blend of technology and live support, Modern Health delivers measurable outcomes, globally equitable access, and sustainable pricing. Our industry-leading Adaptive Care Model and dedicated, human centered, operationally tuned, customer success partners make us a trusted partner for organizations worldwide. Visit us at to learn how we can help you optimize your people and your business.
